A detailed history of Deltec Asset Management LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Deltec Asset Management LLC holds 200,000 shares of KRON stock, worth $200,000. This represents 0.04% of its overall portfolio holdings.

Number of Shares
200,000
Holding current value
$200,000
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

BUY
$0.82 - $1.07 $164,000 - $214,000
200,000 New
200,000 $190,000

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $56.8M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Deltec Asset Management LLC Portfolio

Follow Deltec Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deltec Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Deltec Asset Management LLC with notifications on news.